TrialDiabetes, obesity & metabolism2015

Single-dose new insulin glargine 300 U/ml provides prolonged, stable glycaemic control in Japanese and European people with type 1 diabetes.

M Shiramoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.